Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest EPS Estimates (DBD, NEOG, VIVO, ABAX)

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next year. The earnings estimate for Immucor Inc

BLUD

for the next year ending May, 2012 is $1.23 per share. BLUD's trailing-twelve-month operating margin is 39.07%. Neogen Corporation

NEOG

is expected to earn $1.13 per share over the next year ending May, 2012. NEOG's trailing-twelve-month ROE is 13.25%. Meridian Bioscience Inc

Arrived
Buy shares of homes and vacation rentals for as little as $100.
WiserAdvisor
Get matched with a trusted, local financial advisor for free.
Point.com
Tap into your home's equity to consolidate debt or fund a renovation.
Advantage Gold
Markets are volatile: diversify your retirement fund with a gold IRA.
Robinhood
Move your 401k to Robinhood and get a 3% match on deposits.

VIVO

is likely to earn $0.94 per share in the next year ending September, 2012. VIVO's trailing-twelve-month operating margin is 27.79%. ABAXIS Inc

ABAX

may earn $0.80 per share in the next year ending March, 2012. ABAX's PEG ratio is 1.97.

Trading Ideas.

NEOGNeogen Corp

$4.94-1.00%

Edge Rankings

Momentum4.27

Growth3.11

QualityNot Available

Value30.72

Price Trend

Short

Medium

Long

Overview

Market News and Data brought to you by Benzinga APIs

Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest EPS Estimates (DBD, NEOG, VIVO, ABAX)

Stock Score Locked: Edge Members Only

Edge Rankings

Price Trend

Stock Score Locked: Edge Members Only

Edge Rankings

Price Trend

Comments

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell